Market Tracker

08/30 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.2531
Delayed Data
As of 4:00pm ET
 -0.0025 / -0.98%
Today’s Change
0.24
Today|||52-Week Range
0.65
-30.28%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.26
Today’s open0.26
Day’s range0.25 - 0.26
Volume358,950
Average volume (3 months)599,960
Market cap$54.5M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)+12.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.03-5.48%
OREXOrexigen Therapeutic...+0.16+4.18%
VCELVericel Corp-0.04-1.71%
CASICASI Pharmaceuticals...-0.02-1.74%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts